Literature DB >> 8816465

Transformation by the Bmi-1 oncoprotein correlates with its subnuclear localization but not its transcriptional suppression activity.

K J Cohen1, J S Hanna, J E Prescott, C V Dang.   

Abstract

The bmi-1 oncogene cooperates with c-myc in transgenic mice, resulting in accelerated lymphoma development. Altering the expression of Bmi-1 affects normal embryogenesis. The protein product of bmi-1 is homologous to certain Drosophila Polycomb group proteins that regulate homeotic gene expression through alteration of chromatin structure. Chimeric LexA-Bmi-1 protein has previously been shown to repress transcription. How Bmi-1 functions in embryogenesis and whether this relates to the ability of Bmi-1 to mediate cellular transformation is unknown. We demonstrate here that Bmi-1 is able to transform rodent fibroblasts in vitro, providing a system that has allowed us to correlate its molecular properties with its ability to transform cells. We map functional domains of Bmi-1 involved in transcriptional suppression by using the GAL4 chimeric transcriptional regulator system. Deletion analysis shows that the centrally located helix-turn-helix-turn-helix-turn (HTHTHT) motif is necessary for transcriptional suppression whereas the N-terminal RING finger domain is not required. We demonstrate that nuclear localization requires KRMK (residues 230 to 233) and that the absence of nuclear entry ablates transformation. In addition, we find that the subnuclear localization of wild-type Bmi-1 to the rim of the nucleus requires the RING finger domain and correlates with its ability to transform. Our studies with Bmi-1 deletion mutants suggest that the ability of Bmi-1 to mediate cellular transformation correlates with its unique subnuclear localization but not its transcriptional suppression activity.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8816465      PMCID: PMC231552          DOI: 10.1128/MCB.16.10.5527

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  40 in total

1.  An amino-terminal c-myc domain required for neoplastic transformation activates transcription.

Authors:  G J Kato; J Barrett; M Villa-Garcia; C V Dang
Journal:  Mol Cell Biol       Date:  1990-11       Impact factor: 4.272

2.  Expression of novel DNA-binding protein with zinc finger structure in various tumor cells.

Authors:  M Tagawa; T Sakamoto; K Shigemoto; H Matsubara; Y Tamura; T Ito; I Nakamura; A Okitsu; K Imai; M Taniguchi
Journal:  J Biol Chem       Date:  1990-11-15       Impact factor: 5.157

3.  Transcription activation by the adenovirus E1a protein.

Authors:  J W Lillie; M R Green
Journal:  Nature       Date:  1989-03-02       Impact factor: 49.962

4.  The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene.

Authors:  M J Klemsz; S R McKercher; A Celada; C Van Beveren; R A Maki
Journal:  Cell       Date:  1990-04-06       Impact factor: 41.582

Review 5.  Cytogenetics of T-cell malignant lymphoma. Report of 17 cases and review of the chromosomal breakpoints.

Authors:  R Berger; L Baranger; A Bernheim; F Valensi; G Flandrin; A Berheimm
Journal:  Cancer Genet Cytogenet       Date:  1988-11

6.  Cytogenetic follow-up in a case of Sézary syndrome.

Authors:  E D'Alessandro; P Paterlini; M L Lo Re; M Di Cola; C Ligas; D Quaglino; G Del Porto
Journal:  Cancer Genet Cytogenet       Date:  1990-04

7.  A simple phase-extraction assay for chloramphenicol acyltransferase activity.

Authors:  B Seed; J Y Sheen
Journal:  Gene       Date:  1988-07-30       Impact factor: 3.688

8.  Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins.

Authors:  C V Dang; W M Lee
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

9.  Definition of regions in human c-myc that are involved in transformation and nuclear localization.

Authors:  J Stone; T de Lange; G Ramsay; E Jakobovits; J M Bishop; H Varmus; W Lee
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

10.  Neoplastic transformation by the human gene N-myc.

Authors:  M B Small; N Hay; M Schwab; J M Bishop
Journal:  Mol Cell Biol       Date:  1987-05       Impact factor: 4.272

View more
  31 in total

1.  Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene.

Authors:  B C Lewis; H Shim; Q Li; C S Wu; L A Lee; A Maity; C V Dang
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

2.  Mammalian Scratch: a neural-specific Snail family transcriptional repressor.

Authors:  E K Nakakura; D N Watkins; K E Schuebel; V Sriuranpong; M W Borges; B D Nelkin; D W Ball
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-13       Impact factor: 11.205

3.  Loss of the human polycomb group protein BMI1 promotes cancer-specific cell death.

Authors:  L Liu; L G Andrews; T O Tollefsbol
Journal:  Oncogene       Date:  2006-02-27       Impact factor: 9.867

4.  Ring1A is a transcriptional repressor that interacts with the Polycomb-M33 protein and is expressed at rhombomere boundaries in the mouse hindbrain.

Authors:  J Schoorlemmer; C Marcos-Gutiérrez; F Were; R Martínez; E García; D P Satijn; A P Otte; M Vidal
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

5.  Interference with the expression of a novel human polycomb protein, hPc2, results in cellular transformation and apoptosis.

Authors:  D P Satijn; D J Olson; J van der Vlag; K M Hamer; C Lambrechts; H Masselink; M J Gunster; R G Sewalt; R van Driel; A P Otte
Journal:  Mol Cell Biol       Date:  1997-10       Impact factor: 4.272

6.  Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1.

Authors:  Koji Itahana; Ying Zou; Yoko Itahana; Jose-Luis Martinez; Christian Beausejour; Jacqueline J L Jacobs; Maarten Van Lohuizen; Vimla Band; Judith Campisi; Goberdhan P Dimri
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

7.  The Bmi-1 helix-turn and ring finger domains are required for Bmi-1 antagonism of (-) epigallocatechin-3-gallate suppression of skin cancer cell survival.

Authors:  Sivaprakasam Balasubramanian; Tiffany M Scharadin; Bingshe Han; Wen Xu; Richard L Eckert
Journal:  Cell Signal       Date:  2015-04-02       Impact factor: 4.315

8.  Identification of a polymorphism in the RING finger of human Bmi-1 that causes its degradation by the ubiquitin-proteasome system.

Authors:  Jie Zhang; Kevin D Sarge
Journal:  FEBS Lett       Date:  2009-02-20       Impact factor: 4.124

9.  BMI1 expression identifies subtypes of Merkel cell carcinoma.

Authors:  Maria Kouzmina; Valtteri Häyry; Junnu Leikola; Caj Haglund; Tom Böhling; Virve Koljonen; Jaana Hagström
Journal:  Virchows Arch       Date:  2012-10-11       Impact factor: 4.064

10.  Deletion analysis of BMI1 oncoprotein identifies its negative regulatory domain.

Authors:  Ajay K Yadav; Anagh A Sahasrabuddhe; Manjari Dimri; Prashant V Bommi; Rachana Sainger; Goberdhan P Dimri
Journal:  Mol Cancer       Date:  2010-06-22       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.